首页> 外文期刊>Journal of Medicinal Chemistry >A Highly Selective, Non-Hydantoin, Non-Carboxylic Acid Inhibitor of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2-H-pyridazin-3-one
【24h】

A Highly Selective, Non-Hydantoin, Non-Carboxylic Acid Inhibitor of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2-H-pyridazin-3-one

机译:在糖尿病大鼠模型中具有强口服活性的高选择性,非乙内酰脲,非羧酸醛糖还原酶抑制剂:6-(5-氯-3-甲基苯并呋喃-2-磺酰基)-2-H-哒嗪-3-酮

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We report here on the discovery path that led to a structurally unprecedented non-hydantoin, non-carboxylic acid aldose reductase inhibitor, 24, which shows remarkably potent oral activity in normalizing elevated sorbitol levels and, more significantly, fructose levels in the sciatic nerve of chronically diabetic rats, with ED_(90) values of 0.8 and 3 mpk, respectively. It is well absorbed in rats (oral bioavailability, 98%) and has a long plasma t_(1/2) (26 ± 3 h).
机译:我们在这里报告了发现途径,该发现导致了结构上前所未有的非乙内酰脲,非羧酸醛糖还原酶抑制剂24,在正常化山梨醇水平升高,更重要的是在坐骨神经坐骨神经中果糖水平正常化方面,显示出显着的口服活性慢性糖尿病大鼠,ED_(90)值分别为0.8和3 mpk。它在大鼠中被很好地吸收(口服生物利用度,98%),血浆t_(1/2)长(26±3 h)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号